Transitioning patients with type 1 diabetes from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII)

被引：0
|
作者：
Kumar, RP
Hirsch, IB
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A110 / A110
页数：1
相关论文
共 50 条
  • [41] Comparison of continuous subcutaneous insulin infusion and multiple daily injections in intensive therapy for youths with type 1 diabetes
    Buckloh, LM
    Wilkinson, K
    Sadler, M
    White, NH
    Harris, MA
    Mauras, N
    Fox, L
    Wysocki, T
    DIABETES, 2002, 51 : A425 - A425
  • [42] FEAR OF NEEDLES IN CHILDREN WITH TYPE 1 DIABETES MELLITUS ON MULTIPLE DAILY INJECTIONS AND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    Cemeroglu, Ayse Pinar
    Can, Argun
    Davis, Alan T.
    Cemeroglu, Ozlem
    Kleis, Lora
    Daniel, Maala S.
    Bustraan, Jessica
    Koehler, Tracy J.
    ENDOCRINE PRACTICE, 2015, 21 (01) : 46 - 53
  • [43] An audit of pregnancy outcomes in type 1 diabetes comparing continuous subcutaneous insulin infusion with multiple daily injections
    Hammond, P. J.
    Ray, S.
    Carling, J.
    Dudley, S.
    Dinning, L.
    Johnson, K.
    MacDonald, A.
    DIABETOLOGIA, 2008, 51 : S458 - S458
  • [44] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION VERSUS MULTIPLE DAILY INJECTIONS IN CHILDREN AT ONSET OF TYPE-1 DIABETES
    Jager-Amsellem, J.
    Hasselmann, C.
    Perrodeau, E.
    Faure, N.
    Mercat, I.
    Labarthe, F.
    Bonnemaison, E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A2 - A2
  • [45] MORTALITY RATE OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OR MULTIPLE DAILY INJECTIONS IN JAPAN
    Murata, T.
    Kawaguchi, Y.
    Yamaji, S.
    Yamamoto, R.
    Uenomachi, K.
    Kokubo, A.
    Yoshioka, F.
    Okada, H.
    Watanabe, T.
    Mizutani, Y.
    Yomaida, K.
    Kishi, J.
    Odori, S.
    Nakagawachi, R.
    Satoh-Asahara, N.
    Yamada, K.
    Sakane, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A110 - A111
  • [46] Nocturnal hypoglycemia is not inevitable in type 1 diabetes patients on continuous subcutaneous insulin infusion (CSII)
    Devries, J
    Masurel, N
    Poscia, A
    Heine, R
    DIABETES, 2003, 52 : A92 - A92
  • [47] Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women
    Mello, Giorgio
    Biagioni, Sara
    Ottanelli, Serena
    Nardini, Camilla
    Tredici, Zelinda
    Serena, Caterina
    Marchi, Laura
    Mecacci, Federico
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (03): : 276 - 280
  • [48] Impact of continuous subcutaneous insulin infusion (CSII) therapy on retinopathy in patients with Type 1 diabetes
    Khan, I.
    Hopley, D.
    Glover, L.
    Bett, S.
    Young, S.
    Ratcliffe, J.
    Martin, P.
    Krishnan, S.
    Bharaj, H.
    Banerjee, M.
    DIABETIC MEDICINE, 2019, 36 : 73 - 73
  • [49] Multiple Daily Injections of Insulin Versus Continuous Subcutaneous Insulin Infusion for Pregnant Women With Type 1 Diabetes EDITORIAL COMMENT
    不详
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2013, 68 (10) : 675 - 677
  • [50] BUDGET IMPACT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION COMPARED WITH MULTIPLE DAILY INSULIN INJECTIONS FOR THE TREATMENT OF TYPE 1 DIABETES IN SPAIN
    Elias, I
    Gimenez, M.
    Alvarez, M.
    Quiros, C.
    Conget, I
    VALUE IN HEALTH, 2016, 19 (07) : A689 - A690
12345